Rapivab (BioCryst Pharmaceuticals)
(https://rapivab.com) 📸 Data Snapshot: May 24, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
The primary authority gap is technical rather than content-based, as the site lacks structured schema_json for Drug or MedicalEntity classification. Additionally, while the clinical data is robust, the references are stale, with the most recent ‘Accessed’ dates and package insert citations dating back to March 2021, creating a credibility delta against the 2026 system date. No individual experts are named, which is standard for a drug-specific product site, but the absence of sameAs links to the parent company BioCryst in structured data is a missed opportunity.
There is no disconnect between claims and demonstrations; every marketing assertion is a clinical metric. The claim of a ‘FULL COURSE’ in a single infusion is backed by the Dosing sub-page’s technical preparation steps. Statistical claims regarding symptom resolution are presented with median hour comparisons (79 vs 100), ensuring the marketing tone never exceeds the underlying clinical data.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /dosing-and-administration/ | 0 | 0 |
| /how-supplied/ | 0 | 0 |
| /coding-and-billing/ | 0 | 0 |
This page presents a snapshot of public data from Rapivab (BioCryst Pharmaceuticals), captured on May 24, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Rapivab (BioCryst Pharmaceuticals): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://rapivab.com to view the most current version of its content and see directly what this company is about and what it offers.